MetaADEDB 2.0 @ LMMD
Donepezil
(XWAIAVWHZJNZQQ-UHFFFAOYSA-N)
Structure
SMILES
COc1cc2c(cc1OC)CC(C2=O)CC1CCN(CC1)Cc1ccccc1.Cl
Molecular Formula:
C24H30ClNO3
Molecular Weight:
415.953
Log P:
5.1010
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
38.77
CAS Number(s):
110119-84-1; 120011-70-3
Synonym(s)
1.
Donepezil
2.
1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride
3.
Aricept
4.
Donepezil Hydrochloride
5.
Donepezilium Oxalate Trihydrate
6.
E 2020
7.
E-2020
8.
E2020
9.
Eranz
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1VomitingFAERS: 88
Canada Vigilance: 16
Canada Vigilance
US FAERS
2BradycardiaFAERS: 81
Canada Vigilance: 9
Canada Vigilance
US FAERS
3NauseaFAERS: 71
Canada Vigilance: 28
Canada Vigilance
US FAERS
4DeliriumFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
5DizzinessFAERS: 49
Canada Vigilance: 4
Canada Vigilance
US FAERS
6SomnolenceFAERS: 45
Canada Vigilance: 4
Canada Vigilance
US FAERS
7SyncopeFAERS: 44
Canada Vigilance: 13
Canada Vigilance
US FAERS
8RhabdomyolysisFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
9Drug ineffectiveFAERS: 33
Canada Vigilance: 42
Canada Vigilance
US FAERS
10AgitationFAERS: 31
Canada Vigilance: 5
Canada Vigilance
US FAERS
11Sudden deathFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
12OverdoseFAERS: 27US FAERS
13MalaiseFAERS: 25US FAERS
14AstheniaFAERS: 23
Canada Vigilance: 8
Canada Vigilance
US FAERS
15Cardiac ArrestFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Weight decreasedFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
17DehydrationFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
18FatigueFAERS: 22
Canada Vigilance: 4
Canada Vigilance
US FAERS
19HeadacheFAERS: 21
Canada Vigilance: 2
Canada Vigilance
US FAERS
20TremorFAERS: 19
Canada Vigilance: 4
Canada Vigilance
US FAERS
21Feeling abnormalFAERS: 18US FAERS
22Memory impairmentFAERS: 18
Canada Vigilance: 3
Canada Vigilance
US FAERS
23Altered state of consciousnessFAERS: 16US FAERS
24Abdominal PainFAERS: 15
Canada Vigilance: 4
Canada Vigilance
US FAERS
25Accidental overdoseFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
26DementiaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
27PneumoniaFAERS: 14US FAERS
28Medication ErrorFAERS: 13US FAERS
29Urinary IncontinenceFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
30Depressed Level of ConsciousnessFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
31Mental status changesFAERS: 12US FAERS
32Activities of daily living impairedFAERS: 11US FAERS
33Cerebrovascular accidentFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
34DroolingFAERS: 11US FAERS
35HypotensionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
36PancytopeniaFAERS: 11US FAERS
37RestlessnessFAERS: 11US FAERS
38Sinus bradycardiaFAERS: 11US FAERS
39TorticollisFAERS: 11US FAERS
40Abdominal discomfortFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Atrioventricular BlockFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
42Myocardial InfarctionFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
43AnxietyFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
44Atrial FibrillationFAERS: 9US FAERS
45General physical health deteriorationFAERS: 9US FAERS
46Suicide attemptFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
47AbasiaFAERS: 8US FAERS
48AngerFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Chest PainFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
50EpilepsyFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
51IncontinenceFAERS: 8US FAERS
52Neuroleptic Malignant SyndromeFAERS: 8US FAERS
53ParanoiaFAERS: 8US FAERS
54Product quality issueFAERS: 8US FAERS
55Product substitution issueFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
56AnorexiaFAERS: 7US FAERS
57PallorFAERS: 7US FAERS
58PleurothotonusFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
59ShockFAERS: 7US FAERS
60Sick Sinus SyndromeFAERS: 7US FAERS
61AmnesiaFAERS: 6US FAERS
62AphasiaFAERS: 6US FAERS
63Blood creatine phosphokinase increasedFAERS: 6US FAERS
64Disease ProgressionFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Drug withdrawal syndromeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
66PainFAERS: 6US FAERS
67PruritusFAERS: 6US FAERS
68Urinary tract infectionFAERS: 6US FAERS
69Duodenal UlcerFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Electrolyte imbalanceFAERS: 5US FAERS
71HypersensitivityFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
72LethargyFAERS: 5US FAERS
73Middle insomniaFAERS: 5US FAERS
74Musculoskeletal stiffnessFAERS: 5US FAERS
75PalpitationsFAERS: 5US FAERS
76Personality ChangeFAERS: 5US FAERS
77Accidental drug intake by childFAERS: 4US FAERS
78Accidental exposure to productFAERS: 4US FAERS
79Accidental exposure to product by childFAERS: 4US FAERS
80Accidental exposureFAERS: 4US FAERS
81Acute kidney injuryFAERS: 4US FAERS
82ChoreaFAERS: 4US FAERS
83Completed SuicideFAERS: 4US FAERS
84ConstipationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
85DisorientationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
86DyspepsiaFAERS: 4US FAERS
87Euphoric moodFAERS: 4US FAERS
88HypersomniaFAERS: 4US FAERS
89Incorrect dose administeredFAERS: 4US FAERS
90Intestinal ObstructionFAERS: 4US FAERS
91NasopharyngitisFAERS: 4US FAERS
92NeurodermatitisFAERS: 4US FAERS
93NeutropeniaFAERS: 4US FAERS
94PancreatitisFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
95PresyncopeFAERS: 4US FAERS
96Pulmonary EmbolismFAERS: 4US FAERS
97Respiratory DepressionFAERS: 4US FAERS
98SchizophreniaFAERS: 4US FAERS
99ArthralgiaFAERS: 3US FAERS
100Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
101AutomatismFAERS: 3US FAERS
102Back PainFAERS: 3US FAERS
103Bipolar I disorderFAERS: 3US FAERS
104Blood alkaline phosphatase increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Blood potassium decreasedFAERS: 3US FAERS
106BradykinesiaFAERS: 3US FAERS
107Cerebral InfarctionFAERS: 3US FAERS
108Complex partial seizuresFAERS: 3US FAERS
109CryingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
110DiverticulitisFAERS: 3US FAERS
111Drug administration errorFAERS: 3US FAERS
112Gastric ulcerFAERS: 3US FAERS
113HypomaniaFAERS: 3US FAERS
114Jealous delusionFAERS: 3US FAERS
115Lipase increasedFAERS: 3US FAERS
116Muscle RigidityFAERS: 3US FAERS
117MyalgiaFAERS: 3US FAERS
118Myoglobin blood increasedFAERS: 3US FAERS
119Physical assaultFAERS: 3US FAERS
120PoriomaniaFAERS: 3US FAERS
121Product use in unapproved indicationFAERS: 3US FAERS
122Respiratory FailureFAERS: 3US FAERS
123Respiratory arrestFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Retinal DetachmentFAERS: 3US FAERS
125Rheumatoid ArthritisFAERS: 3US FAERS
126Status EpilepticusFAERS: 3US FAERS
127Unevaluable eventFAERS: 3US FAERS
128UrticariaFAERS: 3US FAERS
129Ventricular FibrillationFAERS: 3US FAERS
130AcarodermatitisFAERS: 2US FAERS
131Adams-Stokes SyndromeFAERS: 2US FAERS
132AkinesiaFAERS: 2US FAERS
133Alanine Aminotransferase IncreasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
134AlopeciaFAERS: 2US FAERS
135AphagiaFAERS: 2US FAERS
136BedriddenFAERS: 2US FAERS
137BelligerenceFAERS: 2US FAERS
138Blood glucose decreasedFAERS: 2US FAERS
139Blood glucose fluctuationFAERS: 2US FAERS
140BruxismFAERS: 2US FAERS
141CatatoniaFAERS: 2US FAERS
142CellulitisFAERS: 2US FAERS
143Cerebral ThrombosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
144Chest discomfortFAERS: 2US FAERS
145ChillsFAERS: 2US FAERS
146ColitisFAERS: 2US FAERS
147Coronary Artery DiseaseFAERS: 2US FAERS
148Depressed moodFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
149Diet refusalFAERS: 2US FAERS
150Disseminated Intravascular CoagulationFAERS: 2US FAERS
151Drug dispensing errorFAERS: 2US FAERS
152Drug level increasedFAERS: 2US FAERS
153Duodenal perforationFAERS: 2US FAERS
154DystoniaFAERS: 2US FAERS
155Emotional distressFAERS: 2US FAERS
156Feeling ColdFAERS: 2US FAERS
157FlushingFAERS: 2US FAERS
158Food aversionFAERS: 2US FAERS
159FractureFAERS: 2US FAERS
160Gamma-Glutamyltransferase IncreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
161GlaucomaFAERS: 2US FAERS
162Heat StrokeFAERS: 2US FAERS
163Hepatic EncephalopathyFAERS: 2US FAERS
164HostilityFAERS: 2US FAERS
165HypophagiaFAERS: 2US FAERS
166HypoventilationFAERS: 2US FAERS
167Impaired work abilityFAERS: 2US FAERS
168InflammationFAERS: 2US FAERS
169Large intestine perforationFAERS: 2US FAERS
170Mallory-Weiss SyndromeFAERS: 2US FAERS
171Mechanical ventilationFAERS: 2US FAERS
172Mental impairmentFAERS: 2US FAERS
173MyoclonusFAERS: 2US FAERS
174Night sweatsFAERS: 2US FAERS
175OphthalmoplegiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
176OverconfidenceFAERS: 2US FAERS
177Product use issueFAERS: 2US FAERS
178PurpuraFAERS: 2US FAERS
179Rash erythematousFAERS: 2US FAERS
180Respiratory distressFAERS: 2US FAERS
181ScreamingFAERS: 2US FAERS
182Septic ShockFAERS: 2US FAERS
183Sleep TalkingFAERS: 2US FAERS
184Stevens-Johnson SyndromeFAERS: 2US FAERS
185StressFAERS: 2US FAERS
186StuporFAERS: 2US FAERS
187TachycardiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
188Thirst decreasedFAERS: 2US FAERS
189ThrombocytopeniaFAERS: 2US FAERS
190ThrombosisFAERS: 2US FAERS
191ToothacheFAERS: 2US FAERS
192Toxicity to various agentsFAERS: 2US FAERS
193Urinary RetentionFAERS: 2US FAERS
194VertigoFAERS: 2US FAERS
195Visual ImpairmentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
196Wrong technique in drug usage processFAERS: 2US FAERS
197Wrong technique in product usage processFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
198jaundiceFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
199Abdominal rigidityFAERS: 1US FAERS
200AbuliaFAERS: 1US FAERS
201AcidosisFAERS: 1US FAERS
202Acute myocardial infarctionFAERS: 1US FAERS
203Acute psychosisFAERS: 1US FAERS
204Alanine aminotransferase decreasedFAERS: 1US FAERS
205Amylase increasedFAERS: 1US FAERS
206AneurysmFAERS: 1US FAERS
207Angle Closure GlaucomaFAERS: 1US FAERS
208Aortic Valve StenosisFAERS: 1US FAERS
209ApathyFAERS: 1US FAERS
210Apparent deathFAERS: 1US FAERS
211ArteriosclerosisFAERS: 1US FAERS
212Aspartate aminotransferase decreasedFAERS: 1US FAERS
213AsphyxiaFAERS: 1US FAERS
214AsthmaFAERS: 1US FAERS
215Atrial tachycardiaFAERS: 1US FAERS
216Benign Prostatic HyperplasiaFAERS: 1US FAERS
217Blood chloride decreasedFAERS: 1US FAERS
218Blood glucose abnormalFAERS: 1US FAERS
219Blood glucose increasedFAERS: 1US FAERS
220Blood pH decreasedFAERS: 1US FAERS
221Blood potassium increasedFAERS: 1US FAERS
222Blood pressure fluctuationFAERS: 1US FAERS
223Blood pressure inadequately controlledFAERS: 1US FAERS
224Blood sodium decreasedFAERS: 1US FAERS
225Blood sodium increasedFAERS: 1US FAERS
226Bowel movement irregularityFAERS: 1US FAERS
227Brief psychotic disorder with marked stressorsFAERS: 1US FAERS
228Bronchial ObstructionFAERS: 1US FAERS
229Burning sensationFAERS: 1US FAERS
230Cardiac DeathFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
231Cardiac procedure complicationFAERS: 1US FAERS
232CardiotoxicityFAERS: 1US FAERS
233CataractFAERS: 1US FAERS
234Cerebral ArteriosclerosisFAERS: 1US FAERS
235Cerebral atrophyFAERS: 1US FAERS
236ChokingFAERS: 1US FAERS
237Cholestatic liver injuryFAERS: 1US FAERS
238ChromaturiaFAERS: 1US FAERS
239Cold sweatFAERS: 1US FAERS
240ConfabulationFAERS: 1US FAERS
241Creatine phosphokinase decreasedFAERS: 1US FAERS
242DeafnessFAERS: 1US FAERS
243Dental cariesFAERS: 1US FAERS
244Diabetes MellitusFAERS: 1US FAERS
245Diabetes mellitus inadequate controlFAERS: 1US FAERS
246DiscomfortFAERS: 1US FAERS
247Drug abuseFAERS: 1US FAERS
248Drug effect incompleteFAERS: 1US FAERS
249Drug screen positiveFAERS: 1US FAERS
250Drug withdrawal convulsionsFAERS: 1US FAERS
251Dry skinFAERS: 1US FAERS
252Duodenal ulcer perforationFAERS: 1US FAERS
253Duodenal ulcer repairFAERS: 1US FAERS
254DysarthriaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
255DysgeusiaFAERS: 1US FAERS
256DysphemiaFAERS: 1US FAERS
257DysuriaFAERS: 1US FAERS
258Economic problemFAERS: 1US FAERS
259EczemaFAERS: 1US FAERS
260Ejection Fraction DecreasedFAERS: 1US FAERS
261Elevated moodFAERS: 1US FAERS
262Emotional disorderFAERS: 1US FAERS
263EnteritisFAERS: 1US FAERS
264Enterococcal infectionFAERS: 1US FAERS
265EnterocolitisFAERS: 1US FAERS
266EosinophiliaFAERS: 1US FAERS
267EructationFAERS: 1US FAERS
268Extra dose administeredFAERS: 1US FAERS
269Eye BurnsFAERS: 1US FAERS
270Flight of ideasFAERS: 1US FAERS
271Food PoisoningFAERS: 1US FAERS
272Food cravingFAERS: 1US FAERS
273Gait inabilityFAERS: 1US FAERS
274GastritisFAERS: 1US FAERS
275GastroenteritisFAERS: 1US FAERS
276General physical condition abnormalFAERS: 1US FAERS
277Haptoglobin increasedFAERS: 1US FAERS
278Heat ExhaustionFAERS: 1US FAERS
279HemiparesisFAERS: 1US FAERS
280Hepatitis CFAERS: 1US FAERS
281HepatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
282HydronephrosisFAERS: 1US FAERS
283HyperkinesiaFAERS: 1US FAERS
284Hypertensive crisisFAERS: 1US FAERS
285HyperthyroidismFAERS: 1US FAERS
286HypokinesiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
287HypoxiaFAERS: 1US FAERS
288IleusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
289ImmobileFAERS: 1US FAERS
290Inappropriate schedule of drug administrationFAERS: 1US FAERS
291Inappropriate schedule of product administrationFAERS: 1US FAERS
292Incorrect drug administration rateFAERS: 1US FAERS
293Increased bronchial secretionFAERS: 1US FAERS
294InfarctionFAERS: 1US FAERS
295InfluenzaFAERS: 1US FAERS
296Initial insomniaFAERS: 1US FAERS
297Injury asphyxiationFAERS: 1US FAERS
298Intentional product misuseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
299Intracranial AneurysmFAERS: 1US FAERS
300IntussusceptionFAERS: 1US FAERS
301LeukoencephalopathyFAERS: 1US FAERS
302LeukopeniaFAERS: 1US FAERS
303Limb injuryFAERS: 1US FAERS
304Lip swellingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
305Living in residential institutionFAERS: 1US FAERS
306Long QT SyndromeFAERS: 1US FAERS
307Lupus-like syndromeFAERS: 1US FAERS
308LymphadenopathyFAERS: 1US FAERS
309LymphomaFAERS: 1US FAERS
310Macular degenerationFAERS: 1US FAERS
311Macular ruptureFAERS: 1US FAERS
312Mastication disorderFAERS: 1US FAERS
313MastoiditisFAERS: 1US FAERS
314MoaningFAERS: 1US FAERS
315Mood swingsFAERS: 1US FAERS
316Muscle SpasticityFAERS: 1US FAERS
317Muscular DystrophyFAERS: 1US FAERS
318Myasthenia GravisFAERS: 1US FAERS
319NecrosisFAERS: 1US FAERS
320Nephrotic SyndromeFAERS: 1US FAERS
321NervousnessFAERS: 1US FAERS
322NeuralgiaFAERS: 1US FAERS
323Ocular icterusFAERS: 1US FAERS
324OligodipsiaFAERS: 1US FAERS
325Oropharyngeal painFAERS: 1US FAERS
326PCO2 increasedFAERS: 1US FAERS
327PO2 decreasedFAERS: 1US FAERS
328PemphigusFAERS: 1US FAERS
329Peptic UlcerFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
330Perforated ulcerFAERS: 1US FAERS
331Pericardial effusionFAERS: 1US FAERS
332PericarditisFAERS: 1US FAERS
333Peripheral swellingFAERS: 1US FAERS
334PeritonitisFAERS: 1US FAERS
335Poor peripheral circulationFAERS: 1US FAERS
336Poverty of speechFAERS: 1US FAERS
337Pressure of speechFAERS: 1US FAERS
338Product administration errorFAERS: 1US FAERS
339Product packaging issueFAERS: 1US FAERS
340PrurigoFAERS: 1US FAERS
341Psychiatric symptomFAERS: 1US FAERS
342Pulmonary FibrosisFAERS: 1US FAERS
343Pulmonary congestionFAERS: 1US FAERS
344RetchingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
345RhinitisFAERS: 1US FAERS
346Senile dementiaFAERS: 1US FAERS
347Septic embolusFAERS: 1US FAERS
348Simple Partial SeizuresFAERS: 1US FAERS
349SinusitisFAERS: 1US FAERS
350Skin UlcerFAERS: 1US FAERS
351Skin reactionFAERS: 1US FAERS
352SomnambulismFAERS: 1US FAERS
353StaringFAERS: 1US FAERS
354Sudden onset of sleepFAERS: 1US FAERS
355Supraventricular tachycardiaFAERS: 1US FAERS
356TenosynovitisFAERS: 1US FAERS
357Thrombocytopenic purpuraFAERS: 1US FAERS
358TinnitusFAERS: 1US FAERS
359Tooth LossFAERS: 1US FAERS
360Toxic Epidermal NecrolysisFAERS: 1US FAERS
361Transaminases increasedFAERS: 1US FAERS
362Unresponsive to stimuliFAERS: 1US FAERS
363Urine output increasedFAERS: 1US FAERS
364VasospasmFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
365Ventricular DysfunctionFAERS: 1US FAERS
366Ventricular arrhythmiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
367Ventricular hypertrophyFAERS: 1US FAERS
368White blood cell count decreasedFAERS: 1US FAERS
369Wrong drug administeredFAERS: 1US FAERS
370Bladder neck obstructionCanada Vigilance: 1Canada Vigilance
371EmbolismCanada Vigilance: 1Canada Vigilance
372EpistaxisCanada Vigilance: 1Canada Vigilance
373Erythema MultiformeCanada Vigilance: 1Canada Vigilance
374FlatulenceCanada Vigilance: 1Canada Vigilance
375Gastrointestinal sounds abnormalCanada Vigilance: 1Canada Vigilance
376HyporeflexiaCanada Vigilance: 1Canada Vigilance
377Loss of personal independence in daily activitiesCanada Vigilance: 1Canada Vigilance
378Pancreatic carcinomaCanada Vigilance: 1Canada Vigilance
379Pathological fractureCanada Vigilance: 2Canada Vigilance
380PhlebitisCanada Vigilance: 1Canada Vigilance
381Product dose omissionCanada Vigilance: 1Canada Vigilance
382Tardive DyskinesiaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.